Literature DB >> 19958824

Bioadhesion and oral absorption of enoxaparin nanocomplexes.

Wei Sun1, Shirui Mao, Yanjun Wang, Varaporn B Junyaprasert, Tingting Zhang, Lidong Na, Juan Wang.   

Abstract

Polyelectrolyte complexes (PEC) formed between chitosan derivatives and enoxaparin were prepared by a self-assembly process and were characterized in terms of particle size and surface charge. The morphology was observed by atomic force microscopy (AFM). The colloidal stability and bioadhesion of the PEC were characterized by dynamic light scattering (DLS). The absorption of enoxaparin in rats was evaluated by activated partial thromboplastin time (APTT) assay. It was shown that the prepared PEC had a spherical shape with positive charge and a mean diameter in the range of 200-600 nm. An increase in temperature led to a decrease in particle size (ca. 10%) with an increased kcps value (ca. 10-20%) for the PEC studied, depending on the polymer structure. Thiolation and methylation of chitosan could significantly improve the corresponding PEC's bioadhesion and hence the oral absorption of enoxaparin. A good relationship between bioadhesion and in vivo absorption was established. However, PEC of PEGylated chitosan did not display a significantly enhanced permeation of enoxaparin compared with unmodified chitosan. In conclusion, the oral bioavailability of enoxaparin can be enhanced by improving the bioadhesive properties of PEC via the chemical modification of chitosan employed. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19958824     DOI: 10.1016/j.ijpharm.2009.11.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.

Authors:  Jianing Meng; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Sci       Date:  2011-06-17       Impact factor: 4.384

2.  Oral delivery of low molecular weight heparin by polyaminomethacrylate coacervates.

Authors:  Angela Viehof; Alf Lamprecht
Journal:  Pharm Res       Date:  2013-05-07       Impact factor: 4.200

3.  Ternary polymeric nanoparticles for oral siRNA delivery.

Authors:  Jing Zhang; Chunbai He; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

4.  Passive targeting and lung tolerability of enoxaparin microspheres for a sustained antithrombotic activity in rats.

Authors:  Shaimaa S Ibrahim; Rihab Osman; Nahed D Mortada; Ahmed-Shawky Geneidy; Gehanne A S Awad
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 5.  Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.

Authors:  Fahad Akhtar; Xinyu Wan; Gang Wu; Samuel Kesse; Shaoda Wang; Shuying He
Journal:  Molecules       Date:  2018-07-18       Impact factor: 4.411

6.  Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.

Authors:  Muhammad Muzamil Khan; Asadullah Madni; Nayab Tahir; Farzana Parveen; Safiullah Khan; Nasrullah Jan; Ahsan Ali; Muhammad Abdurrahim; Umar Farooq; Muhammad Imran Khan
Journal:  Int J Nanomedicine       Date:  2020-03-30

7.  Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation.

Authors:  Bettina Ralay-Ranaivo; Didier Desmaële; Elsa P Bianchini; Elise Lepeltier; Claudie Bourgaux; Delphine Borgel; Thierry Pouget; Jean François Tranchant; Patrick Couvreur; Ruxandra Gref
Journal:  J Control Release       Date:  2014-08-13       Impact factor: 9.776

Review 8.  Advanced delivery strategies facilitating oral absorption of heparins.

Authors:  Guihua Fang; Bo Tang
Journal:  Asian J Pharm Sci       Date:  2020-01-09       Impact factor: 6.598

Review 9.  Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review.

Authors:  M Abd Elgadir; Md Salim Uddin; Sahena Ferdosh; Aishah Adam; Ahmed Jalal Khan Chowdhury; Md Zaidul Islam Sarker
Journal:  J Food Drug Anal       Date:  2014-12-04       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.